CBT
Rank #296Rank #296 by gross profitability (GP/assets 0.24) · ROE 21.1% · Piotroski F-Score 6 / 9.
As-of 2026-07-22 · CIK 0000016040 · all metrics point-in-time as of the filing date.
Financials
Strengthening
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginstable
- Gross profitabilitystable
- Net cashimproving
- Operating marginimproving
- Return on equitystable
- Share count (dilution)improving
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-09-30filed 2025-11-24 | 2024-09-30filed 2024-11-20 | 2023-09-30filed 2023-11-22 | 2022-09-30filed 2022-11-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 3,713.0 | 3,994.0 | 3,931.0 | 4,321.0 |
| Revenue growth (YoY) | -7.0% | 1.6% | -9.0% | 26.8% |
| Gross profit | 940.0 | 960.0 | 839.0 | 885.0 |
| Gross margin | 25.3% | 24.0% | 21.3% | 20.5% |
| Net income | 331.0 | 380.0 | 445.0 | 209.0 |
| Net margin | 8.9% | 9.5% | 11.3% | 4.8% |
| EPS (diluted) | $6.02 | $6.72 | $7.73 | $3.62 |
| EPS growth (YoY) | -10.4% | -13.1% | 113.5% | — |
| Cash flow | ||||
| Operating cash flow | 665.0 | 692.0 | 595.0 | 100.0 |
| Capital expenditures | 274.0 | 241.0 | 244.0 | 211.0 |
| Free cash flow | 391.0 | 451.0 | 351.0 | (111.0) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?